TP53 and cancer: Research on vulvovaginal squamous cell carcinoma indicates that HPV-associated tumors frequently harbor PIK3CA mutations, whereas HPV-independent cancers often exhibit alterations in TERT, TP53, and CDKN2A, emphasizing distinct molecular pathways influenced by HPV types.